The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: A UK population-based outpatient cohort study

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages 1182-1187

  Choi, Hyon K ^a,b,c   Rho, Young Hee ^a   Zhu, Yanyan ^a   Cea Soriano, Lucia ^a   Aviña Zubieta, Juan Antonio ^b,c   Zhang, Yuqing ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TREND STUDY; UNITED KINGDOM;

CARDIOVASCULAR DISEASE; INFLAMMATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AMBULATORY CARE; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK; TIME FACTORS; VENOUS THROMBOSIS;

EID: 84878389664     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201669     Document Type: Article

References (50)

1. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34. (Pubitemid 24011497)
2. Erhardt CC, Mumford PA, Venables PJ, et al. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13. (Pubitemid 19022787)
3. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94. (Pubitemid 24115934)
4. Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
5. Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7. (Pubitemid 34304256)
6. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7. (Pubitemid 36314415)
7. del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45. (Pubitemid 34016192)
8. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11. (Pubitemid 40220344)
9. Park YB, Ahn CW, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-19. (Pubitemid 34774501)
10. Giles JT, Post WS, Blumenthal RS, et al. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2011;63:3216-25.
11. Tam LS, Shang Q, Li EK, et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008;59:1322-31.
12. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010;30:5-6, 8-9.
13. Khan F, Galarraga B, Belch JJ. The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 2010;6:253-61.
14. Borensztajn KS, von der Thüsen JH, Spek CA. The role of coagulation in chronic inflammatory disorders: a jack of all trades. Curr Pharm Des 2011;17:9-16.
15. Nieuwdorp MSE, Meijers JC, Büller H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 2005;5:155-9. (Pubitemid 40378746)
16. Zoller B, Li X, Sundquist J, et al. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012;379:244-9.
17. Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.
18. Matta F, Singala R, Yaekoub AY, et al. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009;101:134-8.
19. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007;5:692-9. (Pubitemid 46563566)
20. O'Neil M, Payne C, Read J. Read Codes Version 3: a user led terminology. Methods Inf Med 1995;34:187-92.
21. Stuart-Buttle CD, Read JD, Sanderson HF, et al. A language of health in action: Read Codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996:75-9.
22. Blak BT, Thompson M. How does the health improvement network (thin) data on prevalence of chronic diseases compare with national figures? Value Health 2009;12:A253.
23. Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393-401. (Pubitemid 46656860)
24. Rodriguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 2010;69:2090-4.
25. Choi HK, Soriano LC, Zhang Y, et al. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012;344:d8190.
26. Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012;71:1273-7.
27. Kim SY, Servi A, Polinski JM, et al. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 2011;13:R32.
28. Solomon DH, Love TJ, Canning C, et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010;69:2114-17.
29. Thomas SL, Edwards CJ, Smeeth L, et al. How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum 2008;59:1314-21.
30. Huerta C, Johansson S, Wallander MA, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007;167:935-43. (Pubitemid 46762756)
31. Toh S, Rodriguez LA, Hernandez-Diaz S. Use of antidepressants and risk of lung cancer. Cancer Causes Control 2007;18:1055-64. (Pubitemid 47498156)
32. Ruigomez A, Martin-Merino E, Rodriguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 2010;19:579-85.
33. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706. (Pubitemid 29126745)
34. Raghunathan TE, Lepkowski JM, Van Hoewyk J, et al. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodology 2001;27:85-95.
35. Rubin DB. Multiple imputation for nonresponse in surveys. New York: J Wiley, 1987.
36. Bacani AK, Gabriel SE, Crowson CS, et al. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012;64:53-61.
37. Zoller B, Li X, Sundquist J, et al. Risk of venous thromboembolism in first- and second-generation immigrants in Sweden. Eur J Intern Med 2012;23:40-7.
38. Virchow RLK. Thrombose und embolie [Thrombosis and emboli]. Massachusetts: Science History Publications, 1998.
39. Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006;367:1075-9.
40. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997;96:3042-7. (Pubitemid 27500106)
41. Bhagat K, Moss R, Collier J, et al. Endothelial ' stunning ' following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 1996;32:822-9. (Pubitemid 26342646)
42. Olech E, Merrill JT. The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr Rheumatol Rep 2006;8:100-8. (Pubitemid 44623977)
43. Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011;164:602-9.
44. Garcia Rodriguez LA, Varas-Lorenzo C, Maguire A, et al. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation 2004;109:3000-6. (Pubitemid 38808323)
45. Martin-Merino E, Garcia-Rodriguez LA, Masso-Gonzalez EL, et al. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol 2009;182:1442-8.
46. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009;18:120-31.
47. Meal A, Leonardi-Bee J, Smith C, et al. Validation of THIN data for non-melanoma skin cancer. Qual Prim Care 2008;16:49-52. (Pubitemid 351454579)
48. Martin-Merino E, Ruigomez A, Johansson S, et al. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry 2010;12:PCC 08m00764.
49. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 2003;108:2726-9. (Pubitemid 37498971)
50. Davies R, Galloway JB, Watson KD, et al. BSRBR Control Centre Consortium BSfRBR. Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011;70:1831-4.